These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4148269)

  • 41. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammatory bowel disease.
    Sachar DB; Janowitz HD
    Dis Mon; 1974 Jul; ():1-44. PubMed ID: 4152917
    [No Abstract]   [Full Text] [Related]  

  • 43. Current status of medical treatment for inflammatory bowel disease.
    Goldstein F
    Am J Gastroenterol; 1983 Dec; 78(12):841-4. PubMed ID: 6139956
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
    Korelitz BI
    Clin Gastroenterol; 1980 May; 9(2):331-49. PubMed ID: 6104550
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of varicella infection during the course of inflammatory bowel disease.
    Mouzas IA; Greenstein AJ; Giannadaki E; Balasubramanian S; Manousos ON; Sachar DB
    Am J Gastroenterol; 1997 Sep; 92(9):1534-7. PubMed ID: 9317080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical treatment of ulcerative colitis and Crohn's disease.
    Rhodes JM
    J Clin Hosp Pharm; 1983 Sep; 8(3):219-32. PubMed ID: 6138368
    [No Abstract]   [Full Text] [Related]  

  • 47. [New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
    Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1987 Apr; 11(4):325-32. PubMed ID: 2884162
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of the results of radical surgical treatment of Crohn disease as related to a diversified postoperative treatment].
    Morettini A; Scartabelli S; Bechi P; Bartolozzi C; Taddei GL; Bartoletti L; D'Albasio G; Allamani A
    Recenti Prog Med; 1981 Jun; 70(6):669-73. PubMed ID: 6115459
    [No Abstract]   [Full Text] [Related]  

  • 49. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An approach to the medical management of inflammatory bowel disease.
    Bartnik W; Shorter RG
    Mater Med Pol; 1981; 13(2):93-9. PubMed ID: 6124660
    [No Abstract]   [Full Text] [Related]  

  • 51. Pulmonary function in patients with inflammatory bowel disease.
    Eade OE; Smith CL; Alexander JR; Whorwell PJ
    Am J Gastroenterol; 1980 Feb; 73(2):154-6. PubMed ID: 6104919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Will there be a next generation of sulfasalazine?
    Goldman P
    Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract]   [Full Text] [Related]  

  • 53. Inflammatory bowel diseases 1977.
    Matuchansky C
    Biomedicine; 1977 Apr; 26(2):98-9. PubMed ID: 17438
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chronic inflammatory intestinal disease and pregnancy].
    Damgaard B; Orholm M
    Ugeskr Laeger; 1984 Jun; 146(23):1701-4. PubMed ID: 6150567
    [No Abstract]   [Full Text] [Related]  

  • 55. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
    Mossop H; Davies P; Murphy MS
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J; Mott CB; Machado MC
    Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D; Katsanos K; Baltayannis G; Tzabouras N; Tsianos EV
    Hepatogastroenterology; 2003; 50(52):1021-4. PubMed ID: 12845970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 59. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
    Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current medical treatment of inflammatory bowel disease].
    Bosques-Padilla F
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.